The global BPH treatment market is expected to grow from USD 33,031.10 million in 2024 to USD 47,045.80 million by 2034, at a ...

Most men over 50 will develop an enlarged prostate. Also called benign prostatic hyperplasia, this bothersome condition makes it hard to urinate and can eventually lead to other problems, such as ...

Winter leads to an increased risk of problems related to the prostate gland in seniors. Cold weather causes urinary and ...

A recent study published in the journal Urology found that Aquablation effectively improved urinary function and preserved or even enhanced sexual function in men with localized p ...

PRNewswire Bangalore Karnataka [India] January 15 Manipal Hospitals Sarjapur Road recently hosted an awareness session on ...

Manipal Hospitals Sarjapur Road hosted a session on HoLEP for Benign Prostatic Hyperplasia. This innovative technique, led by ...

Several conditions can lead to urinary flow problems. In men, prostate changes often affect urination patterns, particularly ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

We are excited to reach this important milestone in the Expander-2 Pivotal Trial,” said Paul Edwards, President and CEO of Prodeon Medical. “Completing enrollment is a key step in our mission to ...